ChemoMetec Raises FY26/27 Revenue and EBITDA Guidance
ChemoMetec now expects FY26/27 revenue of DKK 560—590M (from DKK 545—575M) and EBITDA of DKK 330—345M (from DKK 300—315M).
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
ChemoMetec now expects FY26/27 revenue of DKK 560—590M (from DKK 545—575M) and EBITDA of DKK 330—345M (from DKK 300—315M).